TW252043B - - Google Patents

Info

Publication number
TW252043B
TW252043B TW082108882A TW82108882A TW252043B TW 252043 B TW252043 B TW 252043B TW 082108882 A TW082108882 A TW 082108882A TW 82108882 A TW82108882 A TW 82108882A TW 252043 B TW252043 B TW 252043B
Authority
TW
Taiwan
Prior art keywords
pct
date
sec
formula
pub
Prior art date
Application number
TW082108882A
Other languages
English (en)
Chinese (zh)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of TW252043B publication Critical patent/TW252043B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
TW082108882A 1992-11-05 1993-10-26 TW252043B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929223153A GB9223153D0 (en) 1992-11-05 1992-11-05 Piperazine derivatives

Publications (1)

Publication Number Publication Date
TW252043B true TW252043B (enExample) 1995-07-21

Family

ID=10724559

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082108882A TW252043B (enExample) 1992-11-05 1993-10-26

Country Status (18)

Country Link
US (1) US5827847A (enExample)
EP (1) EP0877612B1 (enExample)
JP (1) JP3238153B2 (enExample)
AT (1) ATE195422T1 (enExample)
AU (1) AU682155B2 (enExample)
CA (1) CA2148593C (enExample)
DE (1) DE69329252T2 (enExample)
DK (1) DK0877612T3 (enExample)
ES (1) ES2149216T3 (enExample)
GB (1) GB9223153D0 (enExample)
GR (1) GR3034400T3 (enExample)
HU (1) HUT72049A (enExample)
LV (1) LV12734B (enExample)
MX (1) MX9306879A (enExample)
PT (1) PT877612E (enExample)
TW (1) TW252043B (enExample)
WO (1) WO1994009780A1 (enExample)
ZA (1) ZA937827B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710481A1 (en) * 1994-11-02 1996-05-08 Duphar International Research B.V Use of flesinoxan for cognition enhancement
US6271234B1 (en) * 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
GB2222768B (en) * 1988-06-17 1992-01-22 Nat Res Dev Analgesic compounds and compositions
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
PT93825B (pt) * 1989-04-22 1996-09-30 Wyeth John & Brother Ltd Processo para a preparacao de derivados da piperazina
NZ233398A (en) * 1989-04-22 1991-12-23 American Home Prod Aryl- or heteroaryl-substituted piperazine derivatives and pharmaceutical compositions
EP0398413A1 (en) * 1989-05-16 1990-11-22 Duphar International Research B.V "3,4-dehydropiperidine derivatives having psychotropic activity
CA2073340C (en) * 1990-01-11 1997-05-20 Hakan Vilhelm Wikstrom Centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
DE4039631A1 (de) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuroprotektive kombination
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
DE4135551A1 (de) * 1991-08-31 1993-03-04 Schering Ag Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen

Also Published As

Publication number Publication date
LV12734A (en) 2001-10-20
CA2148593A1 (en) 1994-05-11
AU5342194A (en) 1994-05-24
AU682155B2 (en) 1997-09-25
HU9501290D0 (en) 1995-06-28
JP3238153B2 (ja) 2001-12-10
JPH08502743A (ja) 1996-03-26
WO1994009780A1 (en) 1994-05-11
EP0877612B1 (en) 2000-08-16
CA2148593C (en) 2005-12-06
ZA937827B (en) 1995-04-21
EP0877612A1 (en) 1998-11-18
DE69329252T2 (de) 2001-03-29
DK0877612T3 (da) 2000-10-09
PT877612E (pt) 2000-11-30
LV12734B (en) 2002-01-20
GR3034400T3 (en) 2000-12-29
DE69329252D1 (de) 2000-09-21
GB9223153D0 (en) 1992-12-16
MX9306879A (es) 1995-01-31
HUT72049A (en) 1996-03-28
ATE195422T1 (de) 2000-09-15
US5827847A (en) 1998-10-27
ES2149216T3 (es) 2000-11-01

Similar Documents

Publication Publication Date Title
IL123142A0 (en) The use of adamantan-derivatives for the treatment of the inner ear
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
MX9708621A (es) AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
CA2176935A1 (fr) Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
MY131641A (en) Indoline derivatives, process of preparation and use
DE69424009D1 (de) Verwendung von (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid zur Herstellung eines Medikaments zur Behandlung von Angst
AU5818394A (en) Use of prodelphinidines for treating arthrosis
ZA941739B (en) Amide derivatives
TW281673B (enExample)
TW252043B (enExample)
AU3386299A (en) N-aryloxyethylamine derivatives for the treatment of depression
DE59308187D1 (en) Substituierte ortho-ethenylphenylessigsäurederivate
GR3021313T3 (en) N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
DE59409645D1 (en) Substituierte arylthioalkylthiopyridine
AU3443593A (en) 4-oxo- and 4H-imidazo(5,1-C)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
ES8605799A1 (es) Procedimiento para la fabricacion de nuevos compuestos cinamoicos
FR2664894B1 (enExample)
GB9304632D0 (en) Amide derivatives
DE59409813D1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen
AU5696594A (en) Triazoloquinazolines for the treatment of diseases of the central vervous system
ES2103232A1 (es) Nuevos compuestos derivados de 1h-imidazol-2-metanol.
MX9603868A (es) Composicion farmaceutica de derivados de indeno para la regulacion de la apoptosis.